UK stocks finish higher as banks, AstraZeneca climb
AstraZeneca rises on late-stage drug trial successUK GDP eyed later in the weekFTSE 100 up 0.9%, FTSE 250 adds 0.2%March...
archivePHAR1
Factbox: Which companies are affected by SVB collapse?
March 13 (Reuters) - Startup-focused lender SVB Financial Group (SIVB.O) last week became the largest bank to fail since the...
Galderma posts 2022 revenue growth ahead of planned IPO
2022 revenue growth up 13.9% to $3.8bn net salesCore earnings (EBITDA) up 14.5% to $791mExpects 6%-9% net sales growth 2023FRANKFURT,...
Novo obesity drug to launch in the UK soon, says watchdog
LONDON, March 8 (Reuters) - Novo Nordisk's (NOVOb.CO) keenly anticipated weight loss medicine, Wegovy, will soon be made available to...
Why Europe’s drug shortages may get worse
Most European countries reporting shortages of antibioticsLow generic drug prices mean razor-thin margins for firmsCompanies say they cannot boost output...
Wall St up as Goldman results keep optimism alive, rising yields cap gains
Goldman Sachs benefits from higher interest ratesMicrosoft rises on report of job cutsIndexes up: Dow 0.89%, S&P 0.96%, Nasdaq 0.90%Oct...
Wall Street rallies after BofA results, UK reversal
Bank of America, BNY benefit from rising interest ratesGrowth stocks jump as Treasury yields fallGoldman Sachs up on report of...
Exclusive: Apollo, Sixth Street no longer in talks to finance Twitter deal
NEW YORK, Oct 5 (Reuters) - Apollo Global Management Inc (APO.N) and Sixth Street Partners, which had been looking to...
